NCT04551222View on ClinicalTrials.gov

The Re-Prosper HF Study

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 9, 2021

Primary Completion Date

June 27, 2025

Study Completion Date

December 31, 2025

Conditions
Heart Failure
Interventions
DRUG

probenecid

1 gr. orally of probenecid twice daily for 180 days

DRUG

Placebo

identical tablets to probenecid

Trial Locations (5)

02130-4817

COMPLETED

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston

45220-2213

RECRUITING

Cincinnati VA Medical Center, Cincinnati, OH, Cincinnati

44106-1702

RECRUITING

Louis Stokes VA Medical Center, Cleveland, OH, Cleveland

02908-4734

RECRUITING

Providence VA Medical Center, Providence, RI, Providence

23249-0001

RECRUITING

Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond

All Listed Sponsors
lead

VA Office of Research and Development

FED